Showing session: reset
PD-1 Pandemonium: FDA Speaks with Industry on the Past, Present, and Future of PD-1 Drugs
- Sort by:
- Browse by:
- Free
- audio + slides
- All slides included
Panel Discussion
Richard Pazdur
U.S. Food and Drug Administration, Silver Spring, MD, United States
Marc Theoret
U.S. Food and Drug Administration, Silver Spring, MD, United States
Israel Lowy
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States
Alan B. Sandler
Genentech, South San Francisco, CA, United States
Hesham A. Abdullah
AstraZeneca Pharmaceuticals LP, Rockville, MD, United States
Scot W. Ebbinghaus
Merck Research Laboratories - Rahway, North Wales, PA, United States
Kevin Chin
EMD Serono, Billerica, MA, United States
Fouad Namouni
Bristol-Myers Squibb Co., Lawrenceville, NJ, United States